Regulation of T-cell migration and effector functions: Insights from in vivo imaging studies

Immunological Reviews

Volumn 221, Issue 1, 2008, Pages 107-129

  Pittet, Mikael J ^a   Mempel, Thorsten R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cell activation; Cell trafficking; Cytotoxicity; In vivo imaging; T cells; Tolerance suppression anergy

Indexed keywords

CD31 ANTIGEN; G PROTEIN COUPLED RECEPTOR; GUANOSINE TRIPHOSPHATASE; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; PROTEIN TYROSINE KINASE; SELECTIN; T LYMPHOCYTE RECEPTOR;

BINDING AFFINITY; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CYTOTOXICITY; EXTRACELLULAR MATRIX; FIBROBLAST; IMAGING; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; CELL COMMUNICATION; CELL MOVEMENT; DIAGNOSTIC IMAGING; HUMANS; T-LYMPHOCYTES;

EID: 38949198691     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2008.00584.x     Document Type: Review

References (230)

1. Springer TA. Adhesion receptors of the immune system. Nature 1990 346 : 425 434.
2. von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. N Engl J Med 2000 343 : 1020 1034.
3. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996 84 : 359 369.
4. Hall A Rho GTPases and the actin cytoskeleton. Science 1998 279 : 509 514.
5. Jacobelli J, Chmura SA, Buxton DB, Davis MM, Krummel MF. A single class II myosin modulates T cell motility and stopping, but not synapse formation. Nat Immunol 2004 5 : 531 538.
6. Miller MJ, Wei SH, Parker I, Cahalan MD. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 2002 296 : 1869 1873.
7. Stoll S, Delon J, Brotz TM, Germain RN. Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science 2002 296 : 1873 1876.
8. Bousso P, Bhakta NR, Lewis RS, Robey E. Dynamics of thymocyte-stromal cell interactions visualized by two-photon microscopy. Science 2002 296 : 1876 1880.
9. Miller MJ, Wei SH, Cahalan MD, Parker I. Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy. Proc Natl Acad Sci USA 2003 100 : 2604 2609.
10. Mempel TR, Henrickson SE, Von Andrian UH. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 2004 427 : 154 159.
11. Lindquist RL, et al. Visualizing dendritic cell networks in vivo. Nat Immunol 2004 5 : 1243 1250.
12. Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain RN. Chemokines enhance immunity by guiding naive CD8+T cells to sites of CD4+T cell-dendritic cell interaction. Nature 2006 440 : 890 895.
13. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991 67 : 1033 1036.
14. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994 76 : 301 314.
15. Alon R, Hammer DA, Springer TA. Lifetime of the P-selectin: carbohydrate bond and its response to tensile force in hydrodynamic flow. Nature 1995 374 : 539.
16. Marshall BT, Long M, Piper JW, Yago T, McEver RP, Zhu C. Direct observation of catch bonds involving cell-adhesion molecules. Nature 2003 423 : 190 193.
17. Jung U, Norman KE, Scharffetter-Kochanek K, Beaudet AL, Ley K. Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo. J Clin Invest 1998 102 : 1526 1533.
18. Henderson RB, et al. The use of lymphocyte function-associated antigen (LFA)-1-deficient mice to determine the role of LFA-1, Mac-1, and alpha4 integrin in the inflammatory response of neutrophils. J Exp Med 2001 194 : 219 226.
19. Salas A, Shimaoka M, Kogan AN, Harwood C, Von Andrian UH, Springer TA. Rolling adhesion through an extended conformation of integrin alpha(L)beta(2) and relation to alpha I and beta I-like domain interaction. Immunity 2004 20 : 393 406.
20. Hoogewerf AJ, et al. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 1997 36 : 13570 13578.
21. Kuschert GS, et al. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 1999 38 : 12959 12968.
22. Stein JV, et al. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J Exp Med 2000 191 : 61 76.
23. Warnock RA, Askari S, Butcher EC, von Andrian UH. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J Exp Med 1998 187 : 205 216.
24. Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and signaling. Annu Rev Immunol 2007 25 : 619 647.
25. Alon R, Dustin ML. Force as a facilitator of integrin conformational changes during leukocyte arrest on blood vessels and antigen-presenting cells. Immunity 2007 26 : 17 27.
26. Giagulli C, et al. RhoA and zeta PKC control distinct modalities of LFA-1 activation by chemokines: critical role of LFA-1 affinity triggering in lymphocyte in vivo homing. Immunity 2004 20 : 25 35.
27. Katagiri K, Maeda A, Shimonaka M, Kinashi T. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat Immunol 2003 4 : 741 748.
28. Brown MJ, et al. Chemokine stimulation of human peripheral blood T lymphocytes induces rapid dephosphorylation of ERM proteins, which facilitates loss of microvilli and polarization. Blood 2003 102 : 3890 3899.
29. Nijhara R, et al. Rac1 mediates collapse of microvilli on chemokine-activated T lymphocytes. J Immunol 2004 173 : 4985 4993.
30. Faure S, et al. ERM proteins regulate cytoskeleton relaxation promoting T cell-APC conjugation. Nat Immunol 2004 5 : 272 279.
31. Shamri R, et al. Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat Immunol 2005 6 : 497 506.
32. Dustin ML, Bromley SK, Zhengyan K, Peterson DA, Unanue ER. Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc Natl Acad Sci USA 1997 94 : 3909 3913.
33. Phillipson M, Heit B, Colarusso P, Liu L, Ballantyne CM, Kubes P. Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade. J Exp Med 2006 203 : 2569 2575.
34. Ryschich E, et al. Active leukocyte crawling in microvessels assessed by digital time-lapse intravital microscopy. J Surg Res 2006 135 : 291 296.
35. Schenkel AR, Mamdouh Z, Muller WA. Locomotion of monocytes on endothelium is a critical step during extravasation. Nat Immunol 2004 5 : 393 400.
36. Auffray C, et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007 317 : 666 670.
37. Vestweber D. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol Rev 2007 218 : 178 196.
38. Carman CV, et al. Transcellular diapedesis is initiated by invasive podosomes. Immunity 2007 26 : 784 797.
39. Marchesi VT, Gowans JL. The migration of lymphocytes through the endothelium of venules in lymph nodes: an electron microscope study. Proc R Soc B 1964 159 : 283 290.
40. Farr AG, De Bruyn PP. The mode of lymphocyte migration through postcapillary venule endothelium in lymph node. Am J Anat 1975 143 : 59 92.
41. Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM. Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP. J Exp Med 1998 187 : 903 915.
42. Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005 6 : 1182 1190.
43. Scimone ML, Felbinger TW, Mazo IB, Stein JV, von Andrian UH, Weninger W. CXCL12 mediates CCR7-independent homing of central memory cells, but not naive T cells, in peripheral lymph nodes. J Exp Med 2004 199 : 1113 1120.
44. Okada T, et al. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med 2002 196 : 65 75.
45. Guarda G, et al. l-selectin-negative CCR7-effector and memory CD8+T cells enter reactive lymph nodes and kill dendritic cells. Nat Immunol 2007 8 : 743 752.
46. Lindbom L, Werr J. Integrin-dependent neutrophil migration in extravascular tissue. Semin Immunol 2002 14 : 115 121.
47. Hayakawa M, Kobayashi M, Hoshino T. Direct contact between reticular fibers and migratory cells in the paracortex of mouse lymph nodes: a morphological and quantitative study. Arch Histol Cytol 1988 51 : 233 240.
48. Gretz JE, Kaldjian EP, Anderson AO, Shaw S. Sophisticated strategies for information encounter in the lymph node: the reticular network as a conduit of soluble information and a highway for cell traffic. J Immunol 1996 157 : 495 499.
49. Katakai T, Hara T, Lee JH, Gonda H, Sugai M, Shimizu A. A novel reticular stromal structure in lymph node cortex: an immuno-platform for interactions among dendritic cells, T cells and B cells. Int Immunol 2004 16 : 1133 1142.
50. Hara T, et al. A transmembrane chemokine, CXC chemokine ligand 16, expressed by lymph node fibroblastic reticular cells has the potential to regulate T cell migration and adhesion. Int Immunol 2006 18 : 301 311.
51. Mueller SN, et al. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 2007 317 : 670 674.
52. Lee JW, et al. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat Immunol 2007 8 : 181 190.
53. Anderson AO, Shaw S. T cell adhesion to endothelium: the FRC conduit system and other anatomic and molecular features which facilitate the adhesion cascade in lymph node. Semin Immunol 1993 5 : 271 282.
54. Bajenoff M, et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 2006 25 : 989 1001.
55. Mempel TR, Junt T, von Andrian UH. Rulers over randomness: stroma cells guide lymphocyte migration in lymph nodes. Immunity 2006 25 : 867 869.
56. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986 137 : 245 254.
57. Hendriks HR, Duijvestijn AM, Kraal G. Rapid decrease in lymphocyte adherence to high endothelial venules in lymph nodes deprived of afferent lymphatic vessels. Eur J Immunol 1987 17 : 1691 1695.
58. Hendriks HR, Eestermans IL. Disappearance and reappearance of high endothelial venules and immigrating lymphocytes in lymph nodes deprived of afferent lymphatic vessels: a possible regulatory role of macrophages in lymphocyte migration. Eur J Immunol 1983 13 : 663 669.
59. Hendriks HR, Eestermans IL, Hoefsmit EC. Depletion of macrophages and disappearance of postcapillary high endothelial venules in lymph nodes deprived of afferent lymphatic vessels. Cell Tissue Res 1980 211 : 375 389.
60. Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med 2001 7 : 213 221.
61. Stoop R, Gal I, Glant TT, McNeish JD, Mikecz K. Trafficking of CD44-deficient murine lymphocytes under normal and inflammatory conditions. Eur J Immunol 2002 32 : 2532 2542.
62. Stoop R, Kotani H, McNeish JD, Otterness IG, Mikecz K. Increased resistance to collagen-induced arthritis in CD44-deficient DBA/1 mice. Arthritis Rheum 2001 44 : 2922 2931.
63. Van Vliet E, Melis M, Foidart JM, Van Ewijk W. Reticular fibroblasts in peripheral lymphoid organs identified by a monoclonal antibody. J Histochem Cytochem 1986 34 : 883 890.
64. Murakami S, Okada H. Lymphocyte-fibroblast interactions. Crit Rev Oral Biol Med 1997 8 : 40 50.
65. Kincade PW, Lee G, Pietrangeli CE, Hayashi S-I, Gimble JM. Cells and molecules that regulate B lymphopoiesis in bone marrow. Annu Rev Immunol 1989 7 : 111 143.
66. Salomon DR, Crisa L, Mojcik CF, Ishii JK, Klier G, Shevach EM. Vascular cell adhesion molecule-1 is expressed by cortical thymic epithelial cells and mediates thymocyte adhesion. Implications for the function of alpha4beta1 (VLA4) integrin in T-cell development. Blood 1997 89 : 2461 2471.
67. St-Pierre Y, Hugo P, Legault D, Tremblay P, Potworowski EF. Modulation of integrin-mediated intercellular adhesion during the interaction of thymocytes with stromal cells expressing VLA-4 and LFA-1 ligands. Eur J Immunol 1996 26 : 2050 2055.
68. Schwarzler C, Oliferenko S, Gunthert U. Variant isoforms of CD44 are required in early thymocyte development. Eur J Immunol 2001 31 : 2997 3005.
69. Parmo-Cabanas M, Garcia-Bernal D, Garcia-Verdugo R, Kremer L, Marquez G, Teixido J. Intracellular signaling required for CCL25-stimulated T cell adhesion mediated by the integrin alpha4beta1. J Leukoc Biol 2007 82 : 380 391.
70. Prockop SE, Palencia S, Ryan CM, Gordon K, Gray D, Petrie HT. Stromal cells provide the matrix for migration of early lymphoid progenitors through the thymic cortex. J Immunol 2002 169 : 4354 4361.
71. Lepesant H, Reggio H, Pierres M, Naquet P. Mouse thymic epithelial cell lines interact with and select a CD3lowCD4+CD8+thymocyte subset through an LFA-1-dependent adhesion-de-adhesion mechanism. Int Immunol 1990 2 : 1021 1032.
72. Kawakami N, Nagerl UV, Odoardi F, Bonhoeffer T, Wekerle H, Flugel A. Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. J Exp Med 2005 201 : 1805 1814.
73. Mrass P, et al. Random migration precedes stable target cell interactions of tumor-infiltrating T cells. J Exp Med 2006 203 : 2749 2761.
74. Boissonnas A, Fetler L, Zeelenberg IS, Hugues S, Amigorena S. In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor. J Exp Med 2007 204 : 345 356.
75. Smith A, Stanley P, Jones K, Svensson L, McDowall A, Hogg N. The role of the integrin LFA-1 in T-lymphocyte migration. Immunol Rev 2007 218 : 135 146.
76. Barreiro O, de la Fuente H, Mittelbrunn M, Sanchez-Madrid F. Functional insights on the polarized redistribution of leukocyte integrins and their ligands during leukocyte migration and immune interactions. Immunol Rev 2007 218 : 147 164.
77. Rose DM, Alon R, Ginsberg MH. Integrin modulation and signaling in leukocyte adhesion and migration. Immunol Rev 2007 218 : 126 134.
78. Friedl P, Entschladen F, Conrad C, Niggemann B, Zanker KS. CD4+T lymphocytes migrating in three-dimensional collagen lattices lack focal adhesions and utilize beta1 integrin-independent strategies for polarization, interaction with collagen fibers and locomotion. Eur J Immunol 1998 28 : 2331 2343.
79. Franitza S, Alon R, Lider O. Real-time analysis of integrin-mediated chemotactic migration of T lymphocytes within 3-D extracellular matrix-like gels. J Immunol Methods 1999 225 : 9 25.
80. Friedl P, Noble PB, Zanker KS. T lymphocyte locomotion in a three-dimensional collagen matrix. Expression and function of cell adhesion molecules. J Immunol 1995 154 : 4973 4985.
81. Porter JC, Hogg N. Integrin cross talk: activation of lymphocyte function-associated antigen-1 on human T cells alters alpha4beta1- and alpha5beta1-mediated function. J Cell Biol 1997 138 : 1437 1447.
82. Dangerfield J, Larbi KY, Huang MT, Dewar A, Nourshargh S. PECAM-1 (CD31) homophilic interaction up-regulates alpha6beta1 on transmigrated neutrophils in vivo and plays a functional role in the ability of alpha6 integrins to mediate leukocyte migration through the perivascular basement membrane. J Exp Med 2002 196 : 1201 1211.
83. Werr J, Xie X, Hedqvist P, Ruoslahti E, Lindbom L. beta1 integrins are critically involved in neutrophil locomotion in extravascular tissue in vivo. J Exp Med 1998 187 : 2091 2096.
84. Werr J, Eriksson EE, Hedqvist P, Lindbom L. Engagement of beta2 integrins induces surface expression of beta1 integrin receptors in human neutrophils. J Leukoc Biol 2000 68 : 553 560.
85. Werr J, Johansson J, Eriksson EE, Hedqvist P, Ruoslahti E, Lindbom L. Integrin alpha(2)beta(1) (VLA-2) is a principal receptor used by neutrophils for locomotion in extravascular tissue. Blood 2000 95 : 1804 1809.
86. Engelmann TW. Neue Methode zur Untersuchung der Sauerstoffausscheidung pflanzlicher und tierischer Organismen. Pflueglers Arch Gesamte Physiol Menschen Tiere 1881 25 : 285 292.
87. Pfeffer W. Locomotorische Richtungsbewegungen durch chemische Reize. Unters Bot Inst Tuebingen 1884 1 : 363 482.
88. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004 22 : 891 928.
89. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLRI, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996 87 : 1037 1047.
90. Forster R, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999 99 : 23 33.
91. Luther SA, Tang HL, Hyman PL, Farr AG, Cyster JG. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci USA 2000 97 : 12694 12699.
92. Allen CD, et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 2004 5 : 943 952.
93. Okada T, Cyster JG. CC chemokine receptor 7 contributes to Gi-dependent T cell motility in the lymph node. J Immunol 2007 178 : 2973 2978.
94. Worbs T, Mempel TR, Bolter J, von Andrian UH, Forster R. CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo. J Exp Med 2007 204 : 489 495.
95. Asperti-Boursin F, Real E, Bismuth G, Trautmann A, Donnadieu E. CCR7 ligands control basal T cell motility within lymph node slices in a phosphoinositide 3-kinase-independent manner. J Exp Med 2007 204 : 1167 1179.
96. Hwang IY, Park C, Kehrl JH. Impaired trafficking of Gnai2+/- and Gnai2-/- T lymphocytes: implications for T cell movement within lymph nodes. J Immunol 2007 179 : 439 448.
97. Rudolph U, et al. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet 1995 10 : 143 150.
98. Huang TT, et al. TCR-mediated hyper-responsiveness of autoimmune Galphai2(-/-) mice is an intrinsic naive CD4(+) T cell disorder selective for the Galphai2 subunit. Int Immunol 2003 15 : 1359 1367.
99. Witt CM, Raychaudhuri S, Schaefer B, Chakraborty AK, Robey EA. Directed migration of positively selected thymocytes visualized in real time. PLoS Biol 2005 3 : e160.
100. Okada T, et al. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol 2005 3 : e150.
101. Kim CH, Pelus LM, White JR, Broxmeyer HE. Differential chemotactic behavior of developing T cells in response to thymic chemokines. Blood 1998 91 : 4434 4443.
102. Campbell JJ, Pan J, Butcher EC. Cutting edge: developmental switches in chemokine responses during T cell maturation. J Immunol 1999 163 : 2353 2357.
103. Tanabe S, et al. Identification of a new mouse beta-chemokine, thymus-derived chemotactic agent 4, with activity on T lymphocytes and mesangial cells. J Immunol 1997 159 : 5671 5679.
104. Okada T, Cyster JG. B cell migration and interactions in the early phase of antibody responses. Curr Opin Immunol 2006 18 : 278 285.
105. Beltman JB, Maree AF, Lynch JN, Miller MJ, de Boer RJ. Lymph node topology dictates T cell migration behavior. J Exp Med 2007 204 : 771 780.
106. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998 392 : 565 568.
107. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999 286 : 2098 2102.
108. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2001 2 : 123 128.
109. Kunkel EJ, Butcher EC. Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002 16 : 1 4.
110. Stein JV, Nombela-Arrieta C. Chemokine control of lymphocyte trafficking: a general overview. Immunology 2005 116 : 1 12.
111. Deane JA, Fruman DA. Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu Rev Immunol 2004 22 : 563 598.
112. Wang F, Herzmark P, Weiner OD, Srinivasan S, Servant G, Bourne HR. Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat Cell Biol 2002 4 : 513 518.
113. Weiner OD, Neilsen PO, Prestwich GD, Kirschner MW, Cantley LC, Bourne HR. A PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity. Nat Cell Biol 2002 4 : 509 513.
114. Stephens L, Smrcka A, Cooke FT, Jackson TR, Sternweis PC, Hawkins PT. A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein beta gamma subunits. Cell 1994 77 : 83 93.
115. Stoyanov B, et al. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 1995 269 : 690 693.
116. Lopez-Ilasaca M, Crespo P, Pellici PG, Gutkind JS, Wetzker R. Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science 1997 275 : 394 397.
117. Tang X, Downes CP. Purification and characterization of Gbetagamma-responsive phosphoinositide 3-kinases from pig platelet cytosol. J Biol Chem 1997 272 : 14193 14199.
118. Hirsch E, et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 2000 287 : 1049 1053.
119. Sasaki T, et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 2000 287 : 1040 1046.
120. Reif K, Okkenhaug K, Sasaki T, Penninger JM, Vanhaesebroeck B, Cyster JG. Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J Immunol 2004 173 : 2236 2240.
121. Nombela-Arrieta C, et al. Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing. Immunity 2004 21 : 429 441.
122. Nombela-Arrieta C, et al. A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress. J Exp Med 2007 204 : 497 510.
123. Matheu MP, Deane JA, Parker I, Fruman DA, Cahalan MD. Class IA phosphoinositide 3-kinase modulates basal lymphocyte motility in the lymph node. J Immunol 2007 179 : 2261 2269.
124. Takesono A, Horai R, Mandai M, Dombroski D, Schwartzberg PL. Requirement for Tec kinases in chemokine-induced migration and activation of Cdc42 and Rac. Curr Biol 2004 14 : 917 922.
125. Fischer AM, Mercer JC, Iyer A, Ragin MJ, August A. Regulation of CXC chemokine receptor 4-mediated migration by the Tec family tyrosine kinase ITK. J Biol Chem 2004 279 : 29816 29820.
126. Rameh LE, Chen CS, Cantley LC. Phosphatidylinositol (3,4,5)P3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine- phosphorylated proteins. Cell 1995 83 : 821 830.
127. Condliffe AM, et al. Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. Blood 2005 106 : 1432 1440.
128. Webb LM, Vigorito E, Wymann MP, Hirsch E, Turner M. Cutting edge: T cell development requires the combined activities of the p110gamma and p110delta catalytic isoforms of phosphatidylinositol 3-kinase. J Immunol 2005 175 : 2783 2787.
129. Fukui Y, et al. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature 2001 412 : 826 831.
130. Kunisaki Y, et al. DOCK2 is a Rac activator that regulates motility and polarity during neutrophil chemotaxis. J Cell Biol 2006 174 : 647 652.
131. Shulman Z, et al. DOCK2 regulates chemokine-triggered lateral lymphocyte motility but not transendothelial migration. Blood 2006 108 : 2150 2158.
132. Garcia-Bernal D, et al. DOCK2 is required for chemokine-promoted human T lymphocyte adhesion under shear stress mediated by the integrin alpha4beta1. J Immunol 2006 177 : 5215 5225.
133. Bousso P, Robey EA. Dynamic behavior of T cells and thymocytes in lymphoid organs as revealed by two-photon microscopy. Immunity 2004 21 : 349 355.
134. Bhakta NR, Oh DY, Lewis RS. Calcium oscillations regulate thymocyte motility during positive selection in the three-dimensional thymic environment. Nat Immunol 2005 6 : 143 151.
135. Iezzi G, Karjalainen K, Lanzavecchia A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 1998 8 : 89 95.
136. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 1998 395 : 82 86.
137. Grakoui A, et al. The immunological synapse: a molecular machine controlling T cell activation. Science 1999 285 : 221 227.
138. Underhill DM, Bassetti M, Rudensky A, Aderem A. Dynamic interactions of macrophages with T cells during antigen presentation. J Exp Med 1999 190 : 1909 1914.
139. Gunzer M, et al. Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity 2000 13 : 323 332.
140. Bousso P, Robey E. Dynamics of CD8+T cell priming by dendritic cells in intact lymph nodes. Nat Immunol 2003 4 : 579 585.
141. Miller MJ, Safrina O, Parker I, Cahalan MD. Imaging the single cell dynamics of CD4+T cell activation by dendritic cells in lymph nodes. J Exp Med 2004 200 : 847 856.
142. Shakhar G, et al. Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo. Nat Immunol 2005 6 : 707 714.
143. Wei SH, Safrina O, Yu Y, Garrod KR, Cahalan MD, Parker I. Ca2+signals in CD4+T cells during early contacts with antigen-bearing dendritic cells in lymph node. J Immunol 2007 179 : 1586 1594.
144. Hugues S, Fetler L, Bonifaz L, Helft J, Amblard F, Amigorena S. Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nat Immunol 2004 5 : 1235 1242.
145. Sims TN, et al. Opposing effects of PKCtheta and WASp on symmetry breaking and relocation of the immunological synapse. Cell 2007 129 : 773 785.
146. Garcia Z, Pradelli E, Celli S, Beuneu H, Simon A, Bousso P. Competition for antigen determines the stability of T cell-dendritic cell interactions during clonal expansion. Proc Natl Acad Sci USA 2007 104 : 4553 4558.
147. Dustin ML, Springer TA. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 1989 341 : 619 624.
148. Varma R, Campi G, Yokosuka T, Saito T, Dustin ML. T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity 2006 25 : 117 127.
149. Maldonado RA, Irvine DJ, Schreiber R, Glimcher LH. A role for the immunological synapse in lineage commitment of CD4 lymphocytes. Nature 2004 431 : 527 532.
150. Dutton RW, Bradley LM, Swain SL. T cell memory. Annu Rev Immunol 1998 16 : 201 223.
151. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000 290 : 92 97.
152. Williams MA, Bevan MJ. Effector and memory CTL differentiation. Annu Rev Immunol 2007 25 : 171 192.
153. Appay V, et al. Characterization of CD4(+) CTLs ex vivo. J Immunol 2002 168 : 5954 5958.
154. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004 21 : 589 601.
155. Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol 2003 3 : 361 370.
156. Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002 20 : 323 370.
157. Stinchcombe JC, Bossi G, Booth S, Griffiths GM. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 2001 15 : 751 761.
158. Stinchcombe JC, Majorovits E, Bossi G, Fuller S, Griffiths GM. Centrosome polarization delivers secretory granules to the immunological synapse. Nature 2006 443 : 462 465.
159. O'Keefe JP, Gajewski TF. Cutting edge: cytotoxic granule polarization and cytolysis can occur without central supramolecular activation cluster formation in CD8+effector T cells. J Immunol 2005 175 : 5581 5585.
160. Purbhoo MA, Irvine DJ, Huppa JB, Davis MM. T cell killing does not require the formation of a stable mature immunological synapse. Nat Immunol 2004 5 : 524 530.
161. Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002 2 : 735 747.
162. Pipkin ME, Lieberman J. Delivering the kiss of death: progress on understanding how perforin works. Curr Opin Immunol 2007 19 : 301 308.
163. Kagi D, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994 369 : 31 37.
164. Brunner KT, Mauel J, Cerottini JC, Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 1968 14 : 181 196.
165. Murali-Krishna K, et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998 8 : 177 187.
166. Pittet MJ, et al. High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med 1999 190 : 705 715.
167. Altman JD, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996 274 : 94 96.
168. Zippelius A, et al. Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. Cancer Res 2004 64 : 2865 2873.
169. Klenerman P, Cerundolo V, Dunbar PR. Tracking T cells with tetramers: new tales from new tools. Nat Rev Immunol 2002 2 : 263 272.
170. Oehen S, Brduscha-Riem K. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J Immunol 1998 161 : 5338 5346.
171. Mempel TR, et al. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 2006 25 : 129 141.
172. Friedman RS, Jacobelli J, Krummel MF. Mechanisms of T cell motility and arrest: deciphering the relationship between intra- and extracellular determinants. Semin Immunol 2005 17 : 387 399.
173. Martinvalet D, Zhu P, Lieberman J. Granzyme A induces caspase-independent mitochondrial damage, a required first step for apoptosis. Immunity 2005 22 : 355 370.
174. Peixoto A, et al. CD8 single-cell gene coexpression reveals three different effector types present at distinct phases of the immune response. J Exp Med 2007 204 : 1193 1205.
175. Veiga-Fernandes H, Walter U, Bourgeois C, McLean A, Rocha B. Response of naive and memory CD8+T cells to antigen stimulation in vivo. Nat Immunol 2000 1 : 47 53.
176. Yang J, Huck SP, McHugh RS, Hermans IF, Ronchese F. Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+T cells in vivo. Proc Natl Acad Sci USA 2006 103 : 147 152.
177. Borrow P, Evans CF, Oldstone MB. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J Virol 1995 69 : 1059 1070.
178. Hermans IF, Ritchie DS, Yang J, Roberts JM, Ronchese F. CD8+T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J Immunol 2000 164 : 3095 3101.
179. Badovinac VP, Harty JT. Adaptive immunity and enhanced CD8+T cell response to Listeria monocytogenes in the absence of perforin and IFN-gamma. J Immunol 2000 164 : 6444 6452.
180. Matloubian M, et al. A role for perforin in downregulating T-cell responses during chronic viral infection. J Virol 1999 73 : 2527 2536.
181. Gunzer M, et al. A spectrum of biophysical interaction modes between T cells and different antigen-presenting cells during priming in 3-D collagen and in vivo. Blood 2004 104 : 2801 2809.
182. Pittet MJ, Zippelius A, Valmori D, Speiser DE, Cerottini JC, Romero P. Melan-A/MART-1-specific CD8 T cells: from thymus to tumor. Trends Immunol 2002 23 : 325 328.
183. Boon T, Coulie PG, Van den Eynde BJ, van der Bruggen P. Human T cell responses against melanoma. Annu Rev Immunol 2006 24 : 175 208.
184. Romero P, et al. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J Exp Med 1998 188 : 1641 1650.
185. Swirski FK, et al. A near-infrared cell tracker for multiscopic in vivo imaging and quantification of leukocyte immune responses. Submitted 2007.
186. Blankenstein T. The role of tumor stroma in the interaction between tumor and immune system. Curr Opin Immunol 2005 17 : 180 186.
187. Sieweke MH, Thompson NL, Sporn MB, Bissell MJ. Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta. Science 1990 248 : 1656 1660.
188. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002 23 : 549 555.
189. Nagaraj S, et al. Altered recognition of antigen is a mechanism of CD8(+) T cell tolerance in cancer. Nat Med 2007 13 : 828 835.
190. Dinapoli MR, Calderon CL, Lopez DM. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene. J Exp Med 1996 183 : 1323 1329.
191. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006 66 : 605 612.
192. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005 5 : 953 964.
193. Kupfer A, Mosmann TR, Kupfer H. Polarized expression of cytokines in cell conjugates of helper T cells and splenic B cells. Proc Natl Acad Sci USA 1991 88 : 775 779.
194. Kupfer H, Monks CR, Kupfer A. Small splenic B cells that bind to antigen-specific T helper (Th) cells and face the site of cytokine production in the Th cells selectively proliferate: immunofluorescence microscopic studies of Th-B antigen-presenting cell interactions. J Exp Med 1994 179 : 1507 1515.
195. Huse M, Lillemeier BF, Kuhns MS, Chen DS, Davis MM. T cells use two directionally distinct pathways for cytokine secretion. Nat Immunol 2006 7 : 247 255.
196. Tadokoro CE, et al. Regulatory T cells inhibit stable contacts between CD4+T cells and dendritic cells in vivo. J Exp Med 2006 203 : 505 511.
197. Tang Q, et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006 7 : 83 92.
198. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 2005 202 : 637 650.
199. Marrack P, Kappler J, Mitchell T. Type I interferons keep activated T cells alive. J Exp Med 1999 189 : 521 530.
200. Le Bon A, et al. Cross-priming of CD8+T cells stimulated by virus-induced type I interferon. Nat Immunol 2003 4 : 1009 1015.
201. Davis MM, Krogsgaard M, Huse M, Huppa J, Lillemeier BF, Li QJ. T cells as a self-referential, sensory organ. Annu Rev Immunol 2007 25 : 681 695.
202. Shevach EM. CD4+CD25+suppressor T cells: more questions than answers. Nat Rev Immunol 2002 2 : 389 400.
203. Chen ML, et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci USA 2005 102 : 419 424.
204. Curiel TJ, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004 10 : 942 949.
205. Dittmer U, et al. Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 2004 20 : 293 303.
206. Lin CY, Graca L, Cobbold SP, Waldmann H. Dominant transplantation tolerance impairs CD8+T cell function but not expansion. Nat Immunol 2002 3 : 1208 1213.
207. Sato E, et al. Intraepithelial CD8+tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 2005 102 : 18538 18543.
208. Thomas DA, Massague J. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 2005 8 : 369 380.
209. Hugues S, et al. Dynamic imaging of chemokine-dependent CD8(+) T cell help for CD8(+) T cell responses. Nat Immunol 2007 8 : 921 930.
210. Sakaguchi S. Naturally arising CD4+regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004 22 : 531 562.
211. Gorelik L, Flavell RA. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000 12 : 171 181.
212. Gorelik L, Flavell RA. Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. Nat Med 2001 7 : 1118 1122.
213. Kullberg MC, et al. TGF-beta1 production by CD4+CD25+regulatory T cells is not essential for suppression of intestinal inflammation. Eur J Immunol 2005 35 : 2886 2895.
214. Hernandez J, Aung S, Marquardt K, Sherman LA. Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens. J Exp Med 2002 196 : 323 333.
215. Snyder JE, Bowers WJ, Livingstone AM, Lee FE, Federoff HJ, Mosmann TR. Measuring the frequency of mouse and human cytotoxic T cells by the Lysispot assay: independent regulation of cytokine secretion and short-term killing. Nat Med 2003 9 : 231 235.
216. Koneru M, Schaer D, Monu N, Ayala A, Frey AB. Defective proximal TCR signaling inhibits CD8+tumor-infiltrating lymphocyte lytic function. J Immunol 2005 174 : 1830 1840.
217. Mustelin T, Vang T, Bottini N. Protein tyrosine phosphatases and the immune response. Nat Rev Immunol 2005 5 : 43 57.
218. Li QJ, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007 129 : 147 161.
219. Speiser DE, et al. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J Exp Med 1999 190 : 775 782.
220. Day CL, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006 443 : 350 354.
221. Petrovas C, et al. PD-1 is a regulator of virus-specific CD8+T cell survival in HIV infection. J Exp Med 2006 203 : 2281 2292.
222. Trautmann L, et al. Upregulation of PD-1 expression on HIV-specific CD8+T cells leads to reversible immune dysfunction. Nat Med 2006 12 : 1198 1202.
223. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+T cell-mediated suppression by dendritic cells. Science 2003 299 : 1033 1036.
224. Peng G, et al. Toll-like receptor 8-mediated reversal of CD4+regulatory T cell function. Science 2005 309 : 1380 1384.
225. Bonasio R, et al. Specific and covalent labeling of a membrane protein with organic fluorochromes and quantum dots. Proc Natl Acad Sci USA 2007 104 : 14753 14758.
226. Weissleder R. Molecular imaging in cancer. Science 2006 312 : 1168 1171.
227. Weissleder R, Tung CH, Mahmood U, Bogdanov A. Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 1999 17 : 375 378.
228. Weissleder R, Kelly K, Sun EY, Shtatland T, Josephson L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 2005 23 : 1418 1423.
229. Boes M, et al. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 2002 418 : 983 988.
230. Link A, et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 2007 8 : 1255 1265.